Barem Research International became the first in the Turkish market research sector that settled a special unit for healthcare studies.

In Barem Research International's early times this settlement run the panel studies among the pharmacists and doctors. In the post 1990 period we became specialised mainly in the ad-hoc studies for this sector. 

This means we are able to advise on the important issues across all aspects of the healthcare sector. From the increased emphasis on and power of patients and the growing importance of consumers as products convert from prescription only to pharmacy or ‘over the counter’ to line extensions and new formulations. From diverting the new drugs or formulations with the best potential and before major investment decisions are made to dealing with positioning and pricing. 

Our expertise covers the following studies in this sector: